Scientific News
A new clinical trial indicates that Bifidobacterium strains can accelerate microbiota maturation, with positive immunological effects in premature babies.
New research suggests that a combination of human milk-derived sugars and the probiotic Bifidobacterium infantis could help manipulate the gut microbiota in ways that may offer therapeutic benefits.
If maternal-child microbial seeding improves health outcomes, it may be a public health strategy that could reduce the prevalence of C-section-associated diseases.
New research highlights how microbial signatures could be used to prevent necrotizing enterocolitis, leading to faster diagnosis.
Together with Prof. Ted Dinan (UCC Ireland) we discuss the link between gut and psychological distress.
New research provides new insights into host-microbiota genetic interactions, shedding light on the role of human genetics on gut microbes.
A new study published in Cell Host & Microbe highlights the association of fibers with the microbiota.
Recurrent UTIs are in part caused by alterations of the gut microbiota and different immune response to bacterial bladder colonization.
New research suggests that hypothalamic neurons use muropeptides as a measure of food intake or of imbalances in the gut microbiota.
New research suggests that the gut microbiota protects the femoral head through the production of extracellular vesicles.
New research suggests that B. infantis can be used to treat children with acute malnutrition.
New research suggests that restoring the gut microbiota’s capacity to sense dietary signals mediated by specific host factors may improve metabolic problems.
Harnessing the human-microbial synergy during pregnancy in the form of probiotics has been shown to impact maternal health and the health of the developing fetus.
The virome might be used in therapeutic approaches: eliminating or replacing disease-driving intestinal viruses with health-promoting viruses may be beneficial for people with IBD.
Patrice Cani (Université catholique de Louvain) discusses the role of Akkermansia muciniphila in the gut barrier.
The crowdfunding phase is open, you can preorder the book from 12 USD as e-book or 24 USD as paperback.
Researchers found that models of conventional risk factors and data on the gut microbiota improved the prediction of liver diseases
New research indicates that the tumor-resident microbiota can promote the formation of metastases as well as the survival of cancer cells during tumor progression.
By analyzing stool samples from dozens of people in Sweden, researchers have found that the microbiota isn’t stable in adulthood.
Researchers have identified 10 species whose abundance was linked to blood levels of TMAO, a metabolite associated with cardiovascular diseases
